MediciNova Inc (MNOV)
2.075
+0.08
(+3.75%)
USD |
NASDAQ |
Nov 22, 13:26
MediciNova Enterprise Value: 53.75M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 53.75M |
| November 20, 2024 | 51.30M |
| November 19, 2024 | 48.85M |
| November 18, 2024 | 43.95M |
| November 15, 2024 | 45.42M |
| November 14, 2024 | 45.17M |
| November 13, 2024 | 53.75M |
| November 12, 2024 | 67.49M |
| November 11, 2024 | 30.70M |
| November 08, 2024 | 30.70M |
| November 07, 2024 | 32.66M |
| November 06, 2024 | 32.17M |
| November 05, 2024 | 34.63M |
| November 04, 2024 | 38.06M |
| November 01, 2024 | 37.08M |
| October 31, 2024 | 38.06M |
| October 30, 2024 | 41.49M |
| October 29, 2024 | 41.49M |
| October 28, 2024 | 35.36M |
| October 25, 2024 | 37.08M |
| October 24, 2024 | 40.51M |
| October 23, 2024 | 40.51M |
| October 22, 2024 | 44.44M |
| October 21, 2024 | 42.96M |
| October 18, 2024 | 44.44M |
| Date | Value |
|---|---|
| October 17, 2024 | 44.19M |
| October 16, 2024 | 46.40M |
| October 15, 2024 | 44.44M |
| October 14, 2024 | 42.47M |
| October 11, 2024 | 42.96M |
| October 10, 2024 | 52.25M |
| October 09, 2024 | 51.30M |
| October 08, 2024 | 51.30M |
| October 07, 2024 | 53.26M |
| October 04, 2024 | 52.77M |
| October 03, 2024 | 52.28M |
| October 02, 2024 | 53.75M |
| October 01, 2024 | 55.23M |
| September 30, 2024 | 58.66M |
| September 27, 2024 | 49.34M |
| September 26, 2024 | 48.36M |
| September 25, 2024 | 54.74M |
| September 24, 2024 | 56.70M |
| September 23, 2024 | 47.87M |
| September 20, 2024 | 48.85M |
| September 19, 2024 | 38.55M |
| September 18, 2024 | 31.68M |
| September 17, 2024 | 38.55M |
| September 16, 2024 | 43.95M |
| September 13, 2024 | 44.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.08M
Minimum
Aug 07 2024
427.66M
Maximum
Jul 27 2020
94.71M
Average
59.97M
Median
Enterprise Value Benchmarks
| BioVie Inc | 38.56M |
| BridgeBio Pharma Inc | 5.857B |
| Ikena Oncology Inc | -54.55M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.628M |
| Total Expenses (Quarterly) | 3.046M |
| EPS Diluted (Quarterly) | -0.05 |
| Earnings Yield | -7.71% |
| Normalized Earnings Yield | -9.157 |